Invivyd Inc (IVVD)
2.37
-0.05
(-2.07%)
USD |
NASDAQ |
May 06, 16:00
2.37
0.00 (0.00%)
After-Hours: 18:54
Invivyd Total Liabilities (Quarterly): 51.71M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.71M |
| September 30, 2023 | 28.42M |
| June 30, 2023 | 33.85M |
| March 31, 2023 | 23.82M |
| December 31, 2022 | 27.20M |
| September 30, 2022 | 47.30M |
| Date | Value |
|---|---|
| June 30, 2022 | 69.77M |
| March 31, 2022 | 96.88M |
| December 31, 2021 | 62.07M |
| September 30, 2021 | 53.06M |
| June 30, 2021 | 542.62M |
| March 31, 2021 | 198.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
23.82M
Minimum
Mar 2023
542.62M
Maximum
Jun 2021
102.91M
Average
52.38M
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 103.53M |
| Viking Therapeutics Inc | 33.63M |
| Stoke Therapeutics Inc | 68.78M |
| 180 Life Sciences Corp | 5.387M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 229.18M |
| Shareholders Equity (Quarterly) | 177.47M |